Status:
COMPLETED
Examining Social, Emotional, and Cognitive Functioning in People With Fragile X and Down Syndromes
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Anxiety Disorders
Child Developmental Disorders, Pervasive
Eligibility:
All Genders
5-25 years
Brief Summary
By testing physiological responses to anxiety in people with nervous system developmental disorders, this study will identify specific physiological characteristics associated with response to anxiety...
Detailed Description
Anxiety is a common and significant problem for people suffering from disorders of nervous system development, including fragile X syndrome. There are few validated treatments for anxiety in people wi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Fragile X premutation or fragile X syndrome, measured by DNA testing; Down syndrome, confirmed by chromosomal analysis; or normally developing control
- Normal hearing
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
511 Patients enrolled
Trial Details
Trial ID
NCT00879515
Start Date
October 1 2005
End Date
September 1 2010
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M.I.N.D. Institute, University of California, Davis
Sacramento, California, United States, 95817